Title : Atorvastatin prevents mesenchymal stem cells from hypoxia and serum-free injury through activating AMP-activated protein kinase.

Pub. Date : 2011 Dec 15

PMID : 20832877






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Atorvastatin prevents mesenchymal stem cells from hypoxia and serum-free injury through activating AMP-activated protein kinase. Atorvastatin protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens
2 Therefore, we hypothesized that atorvastatin could protect MSCs from H/SF injury through AMPK-eNOS pathway. Atorvastatin protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens
3 METHODS AND RESULTS: Stained with Annexin V/propidine iodine (PI), we found atorvastatin (0.001 muM-10 muM) reduced apoptosis of porcine bone marrow-derived MSCs cultured in H/SF condition; however, this effect was obstructed by compound C, an inhibitor of AMPK. Atorvastatin protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens
4 Meanwhile, MSCs treated with atorvastatin increased phosphorylation of AMPK and eNOS. Atorvastatin protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens
5 The uptrend was partially inhibited by compound C. CONCLUSIONS: Atorvastatin can activate AMPK and the phosphorylation of AMPK results in eNOS activated, which provides a novel explanation for the multi-effect of statins on cardiovascular system. Atorvastatin protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens
6 The uptrend was partially inhibited by compound C. CONCLUSIONS: Atorvastatin can activate AMPK and the phosphorylation of AMPK results in eNOS activated, which provides a novel explanation for the multi-effect of statins on cardiovascular system. Atorvastatin protein kinase AMP-activated catalytic subunit alpha 2 Homo sapiens